Polycomb repressive complex 2 (PRC2), which mediates trimethylation of lysine 27 on histone H3 (K27me3), plays an important role in many types of stem cell differentiation. Here, we try to reveal how PRC2, PRC2-mediated repressive histone marker H3K27me3, and active histone marker histone H4 acetylation (acH4) regulate the CD11b transcription during alltrans retinoic acid (ATRA)-induced HL-60 leukemia cell differentiation. By using quantitative real-time polymerase chain reaction (qPCR) and western blot analysis, we found that the mRNA and protein expression levels of two members of PRC2 were decreased during ATRA-induced HL-60 differentiation, respectively. When treated with ATRA for 72 h, the EZH2 and SUZ12 mRNA levels were decreased to 35% and 38% of the control group, respectively. At the same time, the granulocytic mature surface marker CD11b expression was increased significantly at mRNA level detected by qPCR and protein level detected by flow cytometry. By using chromatin immunoprecipitation assay, we compared the local changes in SUZ12 binding and PRC2-mediated H3K27me3 at the promoter of CD11b during ATRA-induced HL-60 differentiation. Both the levels of SUZ12 binding and PRC2-mediated H3K27me3 at the promoter of CD11b were decreased for 4.1 and 3.8 folds, respectively. And we also found the increase in the acH4 level up to 4 folds after 72 h of ATRA treatment. These results suggested that the histone modification including PRC2-mediated repressive histone marker H3K27me3 and active histone marker acH4 may involve in CD11b transcription during HL-60 leukemia cells reprogramming to terminal differentiation.
Introduction
Histone modifications, which include acetylation, methylation, phosphorylation, and so on, can be either repressive or permissive for transcriptional activation, depending on location and context, and are part of the histone code hypothesis [1, 2] . The H3K27me3 modification is carried out by polycomb repressive complex 2 (PRC2), which includes SUZ12, EED, and the histone methyltransferase EZH2 [3 -5] . Among the components of PRC2, the EZH2 enzymatic activity is indispensable for PRC2-mediated gene silencing and SUZ12 is required for this enzymatic activity. H3K27 methylation is thought to provide a binding surface for PRC1, which facilitates oligomerization, condensation of chromatin structure, and inhibition of chromatin remodeling activity in order to maintain silencing. Histone acetylation has been best studied among histone modifications and has been suggested to affect chromatin remodeling and subsequent gene expression. The level of histone acetylation is well correlated with transcriptional activity of many genes. Thus, transcriptionally active euchromatic regions of the genome are often associated with hyperacetylated histones. In general, these histone acetyltransferases preferentially target histones H3 and H4 and acetylate specific lysine residues of their N-terminal tails [6] .
Leukemia is a kind of blood system disease that has defect in hematopoietic precursor cell differentiation. Inducing the leukemia cells to reprogram into normal terminal cells is the major therapy method for leukemia. There are many factors involved in this process, e.g. reestablishing normal patterns of gene expression and cell function by means of chromatin remodeling. Recent studies showed that histone modification, especially PRC2-mediated H3K27me3 participated in the stem cell self-renew and differentiation [7 -9] . However, little is known about the role of histone modification in leukemia cell reprogramming to terminal differentiation.
The CD11b expression is restricted to myeloid cells, and this expression depends upon the stage of differentiation with mature granulocytes and macrophages expressing the highest levels of CD11b surface antigen and mRNA. The HL-60 cell line was established from a patient with acute promyelocyte leukemia. HL-60 cells respond to a variety of inducing agents, including alltrans retinoic acid (ATRA), by ceasing division and acquiring some of the characteristics of the granulocytic lineages, for example, in the appearance of CD11b [10] .
In this study, we investigated the changes of PRC2, PRC2-mediated H3K27me3, and acH4 levels at the promoter region of granulocytic lineages specific gene CD11b during ATRA-induced HL-60 mature myelocytic lineages differentiation.
Materials and Methods
Materials HL-60 cell line was purchased from ATCC (Manassas, USA). ATRA was purchased from Sigma (St Louis, USA). Trizol reagent and reverse transcription kits were purchased from Promega (Madison, USA). SYBR premix Ex Taq kit was purchased from TaKaRa (Dalian, China). All antibodies for western blot analysis including anti-actin, anti-suz12, anti-ezh2, and chromatin immunoprecipitation (ChIP) including anti-suz12, antiH3K27me3, anti-acH4, and ChIP kit were purchased from Upstate (Billerica, USA). Standard ECL development was purchased from GE Healthcare (Piscataway, USA). An anti-CD11b-PE antibody was purchased from BD (Franklin Lakes, USA). General reagents were of analytical grade.
Cell culture
Human leukemia cell line HL-60 were maintained at 378C in 5% CO 2 incubator in the RPMI 1640 medium supplemented with 10% fetal calf serum. ATRA in DMSO was stored at a concentration of 1 Â 10 22 M in the 2208C light-free environment and diluted with culture medium right before use. When used, it was added to HL-60 cells (2 Â 10 5 cells/ml) to get a final concentration of 1 Â 10 26 M. After 24, 48, 72, and 96 h, cells were harvested and washed three times with 0.9% NaCl at 48C by centrifuge at 400g for 5 min.
Quantitative real-time polymerase chain reaction analysis Total RNA from the cultured cells was isolated with Trizol reagent according to the manufacturer's recommended protocol. cDNA was synthesized using 1 mg of RNA with avian myeloblastosis virus-reverse transcriptase enzyme and oligo(dT) 15 prime according to the manufacturer's protocol. Quantitative real-time polymerase chain reaction (qPCR) was conducted using SYBR green PCR master mix reagent and detected by an ABI 7900HT fast real-time PCR system. Each gene transcript level was normalized to b-actin expression levels. The experiment was repeated for three times. Primers used are as follows: b-actin forward:
Western blot analysis
Immunoblotting was carried out according to the standard method. In brief, the cell samples were harvested with SDS lysis buffer (2% SDS, 50 mM dithiothreitol, 62.5 mM Tris -HCl, pH 6.8). After being boiled and sonicated, the samples were loaded to SDS polyacrylamide protein gel, and then transferred onto nitrocellulose membranes. The primary antibodies used including anti-b-actin (1:500), anti-SUZ12 (1:500), and anti-EZH2 (1:500) antibodies. The primary antibodies were probed with corresponding secondary antibodies conjugated with horseradish peroxidase (HRP) (anti-mouse HRP, 1:5000; anti-rabbit HRP, 1:1000) followed by standard ECL development. The experiment was repeated for three times.
Flow cytometric analysis
Flow cytometric analysis was carried out by FACScan. Detailed processes are carried out according to the standard protocol. Basically, cells were washed twice by PBS, and then incubated with anti-CD11b-PE antibody for 15 min at room temperature. Then, the cells were fixed with 4% polyformaldehyde and analyzed by FACScan. CD11b positive rate was determined by
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Chromatin immunoprecipitation
ChIP was performed using a ChIP assay kit according to the manufacturer's instructions. Cells were harvested and fixed with 1% formaldehyde at 378C for 10 min, then washed with phosphate-buffered saline, resuspended in lysis buffer (1% SDS, 10 mM EDTA, and 50 mM TrisHCl, pH 8.1) in the presence of protease inhibitors, sonicated (10 sets of 10 s pulses with the 100% power), and centrifuged to obtain supernatants. The supernatants were pre-cleared by incubating with 60 ml of salmon sperm DNA/protein A agarose beads for 1 h and then incubated overnight with antibodies of anti-SUZ12, antitrimethyl histone H3K27 (each for 4 ml). Immune complexes were collected by incubating with 60 ml of salmon sperm DNA/protein A agarose beads, washed as described using 1 ml of each buffer, and modified histone/DNA complexes were eluted with 500 ml of 1% SDS and 0.1 M NaHCO 3 . After reversal of cross-link, DNA was purified by phenol/chloroform extraction. The qPCR was performed to determine the relative enrichment of gene segments in ChIP compared with input DNA. Reactions were performed in triplicate using SYBR green PCR master mix reagent and detected by an ABI 7900HT fast real-time PCR system. PCR primers were designed within the CD11b promoter region (forward: 5 0 -GGACCTCGGGCTCAAGTAAT-3 0 and reverse: 5 0 -GCCTGTAATGCCAGCACTTT-3 0 ).
Results
Decreased expression of SUZ12 and EZH2 while increased expression of CD11b during ATRA-induced differentiation of HL-60 cells First, we detected the mRNA expression level of two components of PRC2 and CD11b by qPCR. As shown in Fig. 1 , the mRNA expression level of SUZ12 and EZH2 is decreased gradually at different time points during ATRA-induced differentiation. After 72 h of ATRA treatment, the mRNA expression of SUZ12 and EZH2 is only 38% and 35% of the control group (0 h), respectively. But, the mRNA expression of CD11b was increased gradually. Then, we detected the protein expression of SUZ12 and EZH2. The results showed at 72 h post-induced differentiation, the two protein expression levels were reduced significantly (Fig. 2) . FACS of the CD11b expression in ATRA-induced HL-60 cells shows that after 72 h of ATRA treatment, the positive rate of CD11b is increased up to 76% (Fig. 3) . All these data suggested that during ATRA-induced HL-60 differentiation, the PRC2 expression is decreased and the CD11b expression is increased at both mRNA and protein levels. As ATRA-treated time increased, the protein expression of EZH2 and SUZ12 were decreased. b-Actin was used as loaded control.
Regulation of CD11b by PRC2 and acH4 during HL-60 differentiation SUZ12 and H3K27me3 binding decreased at the CD11b promoter region during ATRA-induced HL-60 differentiation By using the ChIP assay, we investigated whether the important subunit SUZ12 of PRC2 located in the promoter of CD11b in HL-60 cells. Lee et al. [11] reported that vast majority of SUZ12 bound sites were found at gene promoters and 95% of the SUZ12 bound regions were found within 1 kb of known or predicted transcription start sites. There are several retinoic acid responsive elements (RAREs) in the promoter of CD11b [12] . So we designed the primer within the proximal promoter of CD11b, and the product includes a RARE. ChIP analysis at the CD11b proximal promoter showed the presence of SUZ12-binding location in HL-60 cells (Fig. 4) , and there was a high extent of SUZ12-binding in HL-60 cells according to the changes of %Input (the amount of DNA immunoprecipitated was normalized by the amount of the amplified DNA in the corresponding nonimmunoprecipitated chromatin solution) at 0 and 72 h (Fig. 5) . As we known, PRC2 catalyzes histone 3 lysine-27 (H3K27) methylation which was the inactive marker on target gene and mediated gene silencing. So at the same time we also found that at the proximal promoter of CD11b in HL-60 cells, it was rich of the transcriptionally non-permissive mark H3K27me3. Furthermore, we took advantage of ChIP assay to compare the local changes in SUZ12 binding and H3K27me3 level at the promoter of CD11b between untreated HL-60 cells and ATRA-treated for 72 h HL-60 cells. The amount of DNA immunoprecipitated with either anti-SUZ12 or H3K27me3 antibody was normalized by the amount of the amplified DNA in the corresponding non-immunoprecipitated chromatin (Input). As shown in Fig. 5 , in untreated control HL-60 cells, there were high levels of SUZ12 binding and H3K27me3 at CD11b promoter region. After treatment with ATRA for 72 h, the SUZ12 and H3K27me3 levels reduced drastically for 4.1 and 3.8 folds, respectively. These data demonstrated that there was a loss of the repressive histone modification at the promoter of CD11b gene during ATRA-induced HL-60 differentiation.
Increased acH4 level at the CD11b promoter during ATRA-induced HL-60 differentiation To determine which roles other histone modifications may play in regulating CD11b expression during ATRA-inducing HL-60 differentiation, we analyzed the local presence of other histone tail modifications using qPCR assays for ChIP analysis (ChIP-qPCR). ChIP-qPCR analysis showed that there was also a rapid the SE from three independent experiments. After being treated with ATRA for 72 h, the SUZ12 binding and H3K27me3 levels at the CD11b proximal promoter were decreased for 4.1 and 3.8 folds, respectively, and the acH4 level at the CD11b proximal promoter was significantly increased for 4 folds.
4-fold increase in acH4 during ATRA-induced differentiation (Fig. 5) . These data suggested that histone H4 acetylation plays an important role in the proper induction of CD11b transcription during HL-60 differentiation.
Discussion
Among regulators, the polycomb group (PcG) proteins are of special importance. These regulators were first described in Drosophila, where they repressed the homeotic genes controlling segment identity in the developing embryo [13] . The initial repression of these genes is carried out by DNA-binding transcriptional repressors, and PcG proteins modify chromatin to maintain these genes in a repressed state [14] . PcG proteins form multiple PRCs that are conserved from Drosophila to humans. The PRCs are brought to the site of initial repression and act by epigenetic modification of chromatin structure to promote gene silencing [15] . To date, two distinct PRCs, PRC1 and PRC2, have been identified. Mammalian PRC1 contains Cbx, Mph, Ring, Bmil, and Mell8 and is thought to be important in the maintenance of gene repression. The second complex, PRC2, contains EZH2, Eed, and SUZ12 and is thought to be involved in the initiation of gene repression [16] .
Recent studies showed that PRC2 and PRC2-mediated H3K27me3 participated in both embryonic and adult stem cells self-renew and differentiation [7, 9, 11] . H3K27me3 is present in key developmental genes that are repressed in the pluripotent stem cells. During differentiation, there is a loss of K27me3, leading to derepression of targets. The function and timing of the alterations in PRC2 activities suggest that these activities are the most likely causes of the onset and progression of tumors, including leukemia which occurs through several mechanisms. For example, PRC2 may induce transcriptional silencing of tumor suppressor genes [17] and promote cancer cell proliferation through interacting with Rb family member [18] . PRC2 also regulate stem cell plasticity by repressing lineage-specific genes. Thus, anomalous PRC2 gene activity might affect the correct expression of lineage-specific genes, thereby impeding the maturation of stem cells and committed progenitors, and allowing the onset and expansion of a 'cancer stem cell'.
Previous studies focused on these normal stem cells differentiation. Leukemia is a disease which is defective in hematopoietic precursor cells differentiation. Inducing the leukemia cell to reprogram into normal terminal cell is the one of important pathway for leukemia therapy. There are many factors participating in the leukemia cells reprogramming to terminal cells. In this study, HL-60 leukemia cells were induced reprogramming to more mature granulocytic cells by treating with ATRA, changes of PRC2 expression and SUZ12-binding level were observed. At the same time, the extent of H3K27me3 and acH4 in the promoter of granulocyticspecific later stage gene CD11b were also observed. HL-60 cells differentiated to more mature cells, and the member genes of PRC2 are decreased significantly at mRNA and protein levels. After being treated with ATRA for 72 h, mRNA expression level of EZH2 and SUZ12 is only 35% and 38% of control cells (0 h), respectively. This result is consistent with previous results [19] that also demonstrated EZH2 was downregulated when HL-60 cells were differentiated to mature granulocytes with ATRA. The expression of CD11b was raised as the expression of PRC2 was decreased. ChIP assay was used to observe whether there is an SUZ12-binding site at the CD11b proximal promoter in HL-60 cells. The primers were designed within the proximal promoter of CD11b, and the product includes a RARE. Our results showed that there was indeed the binding of SUZ12 in the promoter region of CD11b. Furthermore, SUZ12 in the promoter of CD11b is decreased for 4.1 folds in HL-60 cells after being treated with ATRA for 72 h. At the same time, PRC2-mediated H3K27me3 is also diminished on the promoter of CD11b. This suggested that PRC2-mediating modification H3K27me3 was gradually lost as PRC2 expression was decreasing. Lee et al. [20] have reported that during retinoic acid-induced embryonic stem cell differentiation, a class of PRC2 target genes showed rapid loss of EZH2 and H3K27me3 within 14 h, and all of these genes are direct retinoic acid response genes with RAREs. RAREs were found in the promoters of RA response genes consist of variable direct repeats of the sequence PuGGTCA spaced by five nucleotides (DR5). There are also several RAREs in the CD11b promoter region. Retinoic acid is a ligand for the retinoic acid receptor (RAR) family of nuclear receptors. RAR members bind to DNA at RARE which in turn influencing differentiation. Significantly increased CD11b expression level and decreased levels of SUZ12 binding and H3K27me3 at the promoter region of CD11b suggested that the loss of the repressive histone modification regulates CD11b gene transcription during ATRA-induced HL-60 differentiation. Increased CD11b transcription during ATRA-induced HL-60
Regulation of CD11b by PRC2 and acH4 during HL-60 differentiation differentiation is more complicated than simple derepression via loss of H3K27me3. Previous studies suggested that the loss of H3K27me3 was not sufficient for gene transcription, and histone acetylation is important for gene transcription [20] . At the same time, we detected the acH4 level in the promoter of CD11b during ATRA-induced HL-60 cells. The results showed that the acH4 level increased up to 4 folds after ATRA treatment for 72 h. These data suggested that ATRA treatment causes a rapid loss of H3K27me3, but an increased level of acH4 which helps to convert CD11b into activated transcription. It was reported that SUZ12 is essential for PRC2 activity, SUZ12
2/2 ES cells showed global loss of H3K27me3 and higher expression levels of differentiation-specific genes, and SUZ12 is required for the establishment of specific expression programs required for ES cell differentiation [21] . But Plt8 mutation, which impairs SUZ12 mRNA processing and protein production, does not impair HSC differentiation [22] . More research is needed to reveal whether SUZ12 is indispensable for leukemia cell differentiate to mature cells. In conclusion, our studies show that the histone modification includes PRC2-mediated repressive histone marker H3K27me3 and active histone marker acH4 may play an important role in regulating CD11b transcription during HL-60 leukemia cells reprogram to terminal differentiation.
